Fenway Community Health Center, Inc.

Fenway Community Health Center, Inc., a Boston-based nonprofit health center, operates as a federal grant recipient (56% of recent awards as prime recipient) and a subrecipient on federal research grants (44%), with federal work concentrated in HIV prevention and care, sexual health services, substance use disorder treatment, and health equity research for LGBTQ+ populations and underserved communities. Fenway does not hold federal contracts as a prime contractor; its one federal contract award is a $206,209 firm fixed-price purchase order from the CDC Pittsburgh for lateral flow assay evaluation research, completed by January 31, 2026, with performance in Atlanta, Georgia. Fenway's federal footprint is anchored almost entirely in grant work rather than contracting.

Customer concentration is heavily weighted toward the Department of Health and Human Services (HHS) agencies. The top five customer agencies by award count account for 50% of awards, led by HHS Health Resources and Services Administration (18 awards), HHS National Institutes of Health (14 awards), HHS National Institute on Drug Abuse (14 awards), and HHS Housing and Urban Development Assistant Secretary for Community Planning and Development (14 awards). The combined potential value across all 140 awards is $5.5 million, though obligated dollars stand at $263.5 million—a signal that Fenway's awards are primarily ongoing multi-year federal grants with staged funding releases rather than fixed-price procurements. HHS Centers for Disease Control and Prevention Office of Acquisition Services accounts for $5.1 million in combined potential value (2 awards), while CDC Pittsburgh holds $356 thousand across 6 awards.

Fenway serves as a prime grant recipient on awards from the CDC's National Center for HIV/AIDS (Cooperative Agreement, September 1, 2026 through August 31, 2030, $1.2 million, to integrate post-exposure prophylaxis packs into sexual health clinical care for gay, bisexual, and men who have sex with men); from the CDC's National Center for HIV/AIDS (Cooperative Agreement, September 30, 2023 through September 29, 2028, enhancing sexual health services including STI screening, treatment, PrEP navigation, and linkage to HIV care for men who have sex with men and transgender people in the Boston area); from the Department of Justice Office on Violence Against Women (Project Grant CFDA 16.889, October 1, 2023 through September 30, 2026, $600 thousand, for outreach and victim services to LGBTQ survivors of domestic violence, dating violence, sexual assault, and stalking across Massachusetts); and from the National Institute on Aging (Project Grant, September 15, 2024 through December 27, 2026, titled "Bridge to Belonging," a peer-led intervention to reduce loneliness and depression among older gay and bisexual men living with HIV using cognitive behavioral therapy, motivational interviewing, and peer mentorship approaches). Fenway also holds awards from HHS Health Resources and Services Administration under the Ryan White Title III HIV Capacity Development and Planning Grants program, including a $150 thousand FY22 award for telehealth expansion to improve access to HIV care and a $8,919.60 FY24 award for provider education on caring for people living with HIV from BIPOC, gender-diverse, and substance-use-disordered populations.

Fenway acts as a subrecipient on 61 federal grants distributed across a broad research and clinical network. Prime grantees include Johns Hopkins University (North America AIDS Cohort collaboration and HIV/AIDS services research), Boston Medical Center Corporation (PrEP studies with dried blood spot tenofovir-diphosphate measurement and rapid access to PrEP and medication-for-opioid-use disorder), Massachusetts Department of Public Health (substance use disorder services and syringe service program operations), Harvard T.H. Chan School of Public Health (implicit and explicit discrimination exposure research), Brigham and Women's Hospital (chronic pain intervention in people with HIV and digital pill adherence tracking for PrEP), Brown University (syringe service program recruitment and intervention research), Boston University (multi-site HIV prevention and care outcomes study with enrollment of 128 participants), University of Pennsylvania (smoking cessation and anti-vaping intervention development for sexual and gender minority youth), and the City of Boston and Commonwealth of Massachusetts (Housing Opportunities for Persons with AIDS—HOPWA—supportive housing and rental assistance). Fenway also subcontracts under prime contractors Mtnt Construction, LLC and National Opinion Research Center for STIIRC (Sexually Transmitted Infection Incidence, Research, and Capacity) support services, including formative research, participant recruitment, doxycycline post-exposure prophylaxis implementation studies, and mixed-methods research on social and sexual partner meeting venues for men who have sex with men.

Activity has declined from 21 awards in 2024 to 5 in 2026 year-to-date, and only 4 awards face ultimate completion inside the next twenty-four months, presenting minimal recompete cliff exposure. The two named parent vehicles—Indefinite Delivery Contracts 75D30122D14802 and 75D30123D17068—together account for 4 task orders, suggesting minimal IDC-based activity relative to Fenway's grant-dominant posture. Top NAICS categories reflect Fenway's health research and technical services orientation, with "All Other Professional, Scientific, and Technical Services" appearing across 4 awards. Fenway's work is concentrated in Boston, Massachusetts, with multi-site implementation across Massachusetts and participating academic and clinical partner institutions in the Northeast and nationally.